Viewing Study NCT03445169


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT03445169
Status: COMPLETED
Last Update Posted: 2020-11-09
First Post: 2018-02-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-23
Start Date Type: ACTUAL
Primary Completion Date: 2018-05-26
Primary Completion Date Type: ACTUAL
Completion Date: 2018-05-26
Completion Date Type: ACTUAL
First Submit Date: 2018-02-20
First Submit QC Date: None
Study First Post Date: 2018-02-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-05
Last Update Post Date: 2020-11-09
Last Update Post Date Type: ACTUAL